Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Motivational Interviewing After Coronary Stenting

17. juni 2026 oppdatert av: Anita Karaca, Biruni University

The Effect of Motivational Interviewing on Healthy Lifestyle Behaviors and Biochemical Parameters in Patients Undergoing Stent Implantation After Coronary Angiography

This study aimed to examine the effect of motivational interviewing on healthy lifestyle behaviors and biochemical parameters in patients who underwent stent implantation after coronary angiography. Specifically, it investigated whether a structured motivational interviewing program could improve patients' health-promoting behaviors and positively influence biochemical outcomes such as blood lipid levels and body mass index (BMI). The research was designed as a randomized controlled study and was conducted in the cardiology outpatient clinic of a training and research hospital in Istanbul. The study included patients diagnosed with coronary artery disease who had undergone coronary angiography followed by stent implantation and were being followed in the outpatient clinic. Participants were randomly assigned to either the intervention group or the control group. In the intervention group, patients received a motivational interviewing-based program over a three-month period. This program included face-to-face educational sessions lasting approximately 30-45 minutes, focusing on coronary artery disease, risk factors, healthy nutrition, physical activity, stress management, sleep regulation, and smoking cessation. In addition, participants received reminder messages twice a week to support behavioral change and encourage adherence to healthy lifestyle practices. The control group continued their routine medical follow-up and standard care without additional intervention. Data were collected at baseline and at the end of the third month. In the intervention group, data were additionally collected at the end of the first month. Both groups were evaluated using the Health-Promoting Lifestyle Profile II scale, and biochemical parameters including HDL, LDL, total cholesterol, triglycerides, and BMI were measured and recorded. The study aimed to determine whether motivational interviewing could serve as an effective nursing intervention to promote sustainable lifestyle changes and improve clinical outcomes in patients with coronary artery disease following stent implantation.

Studieoversikt

Status

Fullført

Detaljert beskrivelse

Coronary artery disease is characterized by the development of atherosclerotic plaques in the epicardial coronary arteries, leading to progressive narrowing of the vessel lumen and reduced myocardial perfusion. Atherosclerosis is a chronic inflammatory process influenced by modifiable and non-modifiable risk factors. Modifiable risk factors include hypertension, diabetes mellitus, dyslipidemia, smoking, physical inactivity, and unhealthy dietary habits, while non-modifiable factors include age, sex, and genetic predisposition. Coronary artery disease is one of the leading causes of morbidity and mortality worldwide and is associated with major cardiovascular events such as myocardial infarction and stroke.

Lifestyle modification is a fundamental component of both primary and secondary prevention of coronary artery disease. However, a considerable proportion of patients continue unhealthy behaviors following coronary interventions, increasing the risk of recurrent cardiovascular events. For this reason, interventions aimed at promoting sustainable behavioral change are essential in this population. Health-promoting behaviors, including regular physical activity, balanced nutrition, stress management, medication adherence, and smoking cessation, are critical in reducing cardiovascular risk and improving clinical outcomes. Motivational interviewing is a patient-centered counseling approach designed to enhance intrinsic motivation for behavioral change. It is particularly effective in individuals who are ambivalent or resistant to change and is based on principles such as expressing empathy, developing discrepancy between current behaviors and health goals, rolling with resistance, and supporting self-efficacy. This approach is widely used in chronic disease management and nursing practice to support behavioral change.

In this study, a structured motivational interviewing-based intervention supported by educational sessions and reminder messages was developed to improve healthy lifestyle behaviors in patients with coronary artery disease who underwent coronary angiography and stent implantation and were followed in a cardiology outpatient clinic. The intervention was also designed to improve biochemical parameters, including lipid profile indicators and body mass index. This randomized controlled trial was conducted in the cardiology outpatient clinic of a tertiary training and research hospital in Istanbul, Türkiye. The study population consisted of adult patients with coronary artery disease who underwent stent implantation following coronary angiography and were under outpatient follow-up. The sample size was determined using a power analysis. Participants were allocated to the intervention and control groups using simple randomization. Inclusion criteria included age 18 years or older, ability to read and understand Turkish, at least one month post-stent implantation or balloon angioplasty, clinical stability, and access to a mobile phone. Patients with psychiatric disorders affecting participation, communication difficulties, or severe clinical instability were excluded.

The intervention group received a structured face-to-face educational session covering coronary artery disease, risk factors, nutrition, physical activity, stress management, sleep hygiene, and smoking cessation, followed by motivational interviewing sessions and twice-weekly reminder messages for three months. The control group received routine clinical follow-up without additional intervention. Health-promoting lifestyle behaviors were assessed using the Health-Promoting Lifestyle Profile II scale. Biochemical outcomes, including lipid profile parameters (HDL, LDL, total cholesterol, triglycerides) and body mass index, were used to evaluate clinical outcomes. Assessments were performed at baseline, at one month, and at three months. Body mass index was calculated as weight in kilograms divided by height in meters squared. Data were collected using standardized instruments and analyzed using appropriate statistical methods. Statistical significance was set at p < 0.05. Ethical approval was obtained from the relevant institutional ethics committee, and written informed consent was obtained from all participants before enrollment.

Studietype

Intervensjonell

Registrering (Faktiske)

55

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Zeytinburnu
      • Istanbul, Zeytinburnu, Tyrkia (Türkiye), 34010
        • Biruni University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Patients aged over 18 years,
  • Able to understand Turkish and literate,
  • Patients who had undergone stent placement after coronary angiography (at least 1 month after stent implantation or balloon angioplasty),
  • Patients whose health status was appropriate for participation in the study,
  • Patients who owned a mobile phone.

Exclusion Criteria:

  • Patients with a diagnosed psychiatric disorder,
  • Patients with whom communication could not be established,
  • Patients with poor general health status.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Motivational Interviewing Program Group
Participants received a motivational interviewing program supported by education and twice-weekly reminder messages for three months in addition to routine outpatient follow-up.
A structured motivational interviewing program delivered by a trained researcher, supported by patient education and reminder messages aimed at improving healthy lifestyle behaviors and cardiovascular risk factor management.
Ingen inngripen: Routine Care Control Group
Participants received routine cardiology outpatient follow-up and standard care without motivational interviewing or reminder messages.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Health-Promoting Lifestyle Behaviors
Tidsramme: Baseline, 1 month (intervention group), and 3 months after intervention.
Health-promoting lifestyle behaviors were assessed using the Health-Promoting Lifestyle Profile II (HPLP-II) scale. The scale consisted of six sub-dimensions: spiritual growth, interpersonal relationships, nutrition, physical activity, health responsibility, and stress management.
Baseline, 1 month (intervention group), and 3 months after intervention.
Blood Lipid Profile
Tidsramme: Baseline and 3 months after intervention.
Blood lipid parameters including HDL cholesterol, LDL cholesterol, total cholesterol, and triglycerides were measured using a biochemical monitoring form.
Baseline and 3 months after intervention.
Body Mass Index (BMI)
Tidsramme: Baseline and 3 months after intervention.
Body mass index was calculated as weight in kilograms divided by height in meters squared (kg/m²).
Baseline and 3 months after intervention.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

17. november 2025

Primær fullføring (Faktiske)

10. desember 2025

Studiet fullført (Faktiske)

10. mars 2026

Datoer for studieregistrering

Først innsendt

11. juni 2026

Først innsendt som oppfylte QC-kriteriene

17. juni 2026

Først lagt ut (Faktiske)

22. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

22. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

17. juni 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere